Development and Clinical Validation of a Novel Inflamm-Aging Score in Cardiovascular Disease

Aiad Gaber Arean; Amenh Mohammed Abdulrahman; Abdullah Ali Mohammed; Waleed Khalid Ahmed; Youssef Shakuri Yasin; Azal Hamoody Jumaa

doi:10.24017/science.2026.1.14

Authors

Aiad Gaber Arean Department of Medical Chemistry, College of Medicine , Al-Muthanna University, Al-Muthanna , Iraq. https://orcid.org/0009-0003-6258-2026
Amenh Mohammed Abdulrahman Department of Pharmacology , College of medicine. Al-Iraqia university, Baghdad, Iraq. https://orcid.org/0009-0008-2596-2560
Abdullah Ali Mohammed Department of Medical Chemistry, College of Medicine, University of Fallujah, Al-Fallujah, Iraq. https://orcid.org/0000-0002-5717-6694
Waleed Khalid Ahmed Department of Medical Chemistry, College of Medicine, University of Fallujah, Al-Fallujah, Iraq. https://orcid.org/0009-0000-8683-541X
Youssef Shakuri Yasin Bilad Alrafidain University, Diyala, Iraq. https://orcid.org/0000-0003-1433-1858
Azal Hamoody Jumaa Iraqi National Cancer Research Center/the University of Baghdad, Baghdad, Iraq. https://orcid.org/0000-0001-8497-0001

Abstract

Chronic low-grade inflammation associated with aging "inflamm-aging" contributes to cardiovascular disease (CVD), yet traditional risk assessment relies on single biomarkers. This cross-sectional study aims to evaluate and validate a composite inflamm-aging score in 65 patients with CVD and 55 age-matched healthy controls. The score was derived from three biomarkers of interleukin 6 (IL-6), high-sensitivity c-reactive protein (hsCRP), and matrix metalloproteinase-9 (MMP9)- using principal component analysis (PCA). The PCA yielded one component with an eigenvalue of 2.172 (72.4% variance), and the second component's eigenvalue was 0.52 (<1.0, Kaiser criterion). The biomarker loadings were IL-6 (0.58), hsCRP (0.54), and MMP9 (0.61). The weighted composite was adjusted for age (β = 0.045/year, p=0.002) and sex (β = 0.31 female vs. male, p = 0.018) using multiple linear regression among the controls (R² = 0.246). The final score was calculated as the residual. The score distinguished CVD from the controls with an area under the curve of 0.89 (an optimal cutoff of >1.20) with 81.5% sensitivity and 87.3% specificity. The score correlated strongly with N-terminal pro-B-type natriuretic peptide (ρ=0.71) and the soluble suppression of tumorigenicity 2 (ρ=0.58), independent of traditional risk factors including hypertension, diabetes, and dyslipidemia. A significant age-by-disease interaction (p=0.008) indicated accelerated inflamm-aging in older CVD patients. The inflamm-aging score is a promising novel biomarker of CVD severity beyond traditional assessments, potentially guiding individualized anti-inflammatory therapy. Independent external validation is required before clinical implementation.

Keywords:

Inflamm-aging score, Cardiovascular disease, IL-6, hs-CRP, MMP9, Pleiotropic effects

References

G. Victor, K. Shishani, E. Vellone, and E. S. Froelicher, "The global burden of cardiovascular disease in adults: a mapping review," Journal of Cardiovascular Nursing, p. 10.1097, 2025. doi: 10.1097/JCN.0000000000001200. DOI: https://doi.org/10.1097/JCN.0000000000001200

G. A. Roth et al., "Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study," Journal of the American College of Cardiology, vol. 76, no. 25, pp. 2982-3021, 2020. doi: 10.1016/j.jacc.2020.11.010. DOI: https://doi.org/10.1016/j.jacc.2020.11.021

J. Ayoub, H. Leppäniemi, A. Al-Jawaldeh, and M. Taktouk, "Management of noncommunicable diseases in the Eastern Mediterranean Region. doi: 10.17605/osf.io/gkfsc.

M. A. Jalal et al., "Epidemiological trends and clinical characteristics of measles in Iraq (2023–2024): a retrospective cross-sectional study," BMC Infectious Diseases, vol. 25, no. 1, p. 487, 2025. doi: 10.1186/s12879-025-10904-8. DOI: https://doi.org/10.1186/s12879-025-10904-8

W. H. Organization, Suicide worldwide in 2021: Global Health Estimates. World Health Organization, 2025. ISBN: 978-92-4-011006-9.

S. Zivkovic, G. Maric, N. Cvetinovic, D. Lepojevic-Stefanovic, and B. Bozic Cvijan, "Anti-inflammatory effects of lipid-lowering drugs and supplements—a narrative review," Nutrients, vol. 15, no. 6, p. 1517, 2023. doi: 10.3390/nu15061517. DOI: https://doi.org/10.3390/nu15061517

D. Yu and J. K. Liao, "Emerging views of statin pleiotropy and cholesterol lowering," Cardiovascular Research, vol. 118, no. 2, pp. 413-423, 2022. doi: 10.1093/cvr/cvab032. DOI: https://doi.org/10.1093/cvr/cvab032

M. Abohelwa, J. Kopel, S. Shurmur, M. M. Ansari, Y. Awasthi, and S. Awasthi, "The Framingham study on cardiovascular disease risk and stress-defenses: a historical review," Journal of Vascular Diseases, vol. 2, no. 1, pp. 122-164, 2023. doi: 10.3390/jvd2010010. DOI: https://doi.org/10.3390/jvd2010010

E. W. Abd El-Wahab, "Predicting coronary heart disease using risk assessment charts and risk factor categories," Journal of Public Health, vol. 29, no. 5, pp. 1037-1045, 2021. doi: 10.1007/s10389-020-01224-z. DOI: https://doi.org/10.1007/s10389-020-01224-z

J. P. Ferreira, F. Vasques-Nóvoa, J. S. Neves, F. Zannad, and A. Leite-Moreira, "Comparison of interleukin-6 and high-sensitivity C-reactive protein for cardiovascular risk assessment: findings from the MESA study," Atherosclerosis, vol. 390, p. 117461, 2024. doi: 10.1016/j.atherosclerosis.2024.117461. DOI: https://doi.org/10.1016/j.atherosclerosis.2024.117461

Y.-H. Chan and D. P. Ramji, "Key roles of inflammation in atherosclerosis: Mediators involved in orchestrating the inflammatory response and its resolution in the disease along with therapeutic avenues targeting inflammation," in: Ramji, D. (eds) Atherosclerosis. Methods in Molecular Biology, vol 2419. Humana, New York, NY. vol. 2419, pp. 21-37, 2022. doi: 10.1007/978-1-0716-1924-7_2. DOI: https://doi.org/10.1007/978-1-0716-1924-7_2

K. Kalra et al., "Skeletal muscle-cardiac muscle aging: shared mechanisms and multimodal Interventions," JACC: Advances, vol. 4, no. 12_Part_1, p. 102347, 2025. doi: 10.1016/j.jacadv.2025.102347. DOI: https://doi.org/10.1016/j.jacadv.2025.102347

L. Nedkoff et al., "Sex-and age-specific differences in risk profiles and early outcomes in adults with acute coronary syndromes," Heart, Lung and Circulation, vol. 33, no. 3, pp. 332-341, 2024. doi: 10.1016/j.hlc.2023.11.016. DOI: https://doi.org/10.1016/j.hlc.2023.11.016

M. Learmonth, A. Corker, S. Dasgupta, K. Y. DeLeon-Pennell, and K. Y. DeLeon-Pennell, "Regulation of cardiac fibroblasts by lymphocytes after 1 playing in the major league 2." American Journal of Physiology-Heart and Circulatory Physiology, vol. 325, no. 3, pp. H-553-H561, 2023. doi: 10.1152/ajpheart.00250.2023. DOI: https://doi.org/10.1152/ajpheart.00250.2023

M. Torzewski, "The initial human atherosclerotic lesion and lipoprotein modification—a deep connection," International Journal of Molecular Sciences, vol. 22, no. 21, p. 11488, 2021. doi: 10.3390/ijms222111488. DOI: https://doi.org/10.3390/ijms222111488

A. Imbesi, A. Greco, and D. Capodanno, "Anti-inflammatory strategies for patients with atherosclerotic coronary disease," Expert Review of Cardiovascular Therapy, vol. 23, no. 11, pp. 703-721, 2025. doi: 10.1080/14779072.2025.2564137. DOI: https://doi.org/10.1080/14779072.2025.2564137

S. Costanzo et al., "Reduced pulmonary function, low-grade inflammation and increased risk of total and cardiovascular mortality in a general adult population: prospective results from the Moli-sani study," Respiratory Medicine, vol. 184, p. 106441, 2021. doi: 10.1016/j.rmed.2021.106441. DOI: https://doi.org/10.1016/j.rmed.2021.106441

M. Bonaccio et al., "Association of a traditional Mediterranean diet and non-Mediterranean dietary scores with all-cause and cause-specific mortality: prospective findings from the Moli-sani Study," European Journal of Nutrition, vol. 60, no. 2, pp. 729-746, 2021. doi: 10.1007/s00394-020-02272-7. DOI: https://doi.org/10.1007/s00394-020-02272-7

W. H. Organization, Best practices for haemoglobin measurement in population-level anaemia surveys: technical brief. World Health Organization, 2024. ISBN: 9789240087651.

M. Abinti et al., "Associations of intact and C-terminal FGF23 with inflammatory markers in older patients affected by advanced chronic kidney disease," Journal of Clinical Medicine, vol. 13, no. 13, p. 3967, 2024. doi: 10.3390/jcm13133967. DOI: https://doi.org/10.3390/jcm13133967

F. Z. Rahali, N. Mimouni, A. Boukhira, and S. Chellak, "The clinical utility of standard and high-sensitivity C-Reactive protein: a narrative review," SN Comprehensive Clinical Medicine, vol. 6, no. 1, p. 65, 2024. doi: 10.1007/s42399-024-01693-3. DOI: https://doi.org/10.1007/s42399-024-01693-3

S. Blankenberg et al., "Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease," Circulation, vol. 107, no. 12, pp. 1579-1585, 2003. doi: 10.1161/01.CIR.0000058700.41738.12. DOI: https://doi.org/10.1161/01.CIR.0000058700.41738.12

J. L. Januzzi et al., "NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: The international collaborative of NT-proBNP Study," European Heart Journal, vol. 27, no. 3, pp. 330-337, 2006. doi: 10.1093/eurheartj/ehi631. DOI: https://doi.org/10.1093/eurheartj/ehi631

B. Dieplinger and T. Mueller, "Soluble ST2 in heart failure," Clinica Chimica Acta, vol. 443, pp. 57-70, 2015. doi: 10.1016/j.cca.2014.09.021. DOI: https://doi.org/10.1016/j.cca.2014.09.021

Z. Katambara, "Multivariate analysis of evaporation drivers in mbeya, tanzania using principal component analysis," Asian Journal of Water, Enviroment and Pollution, vol. 22, no. 5 pp. 231-244, 2024. doi: 10.36922/AJWEP025250201. DOI: https://doi.org/10.36922/AJWEP025250201

A. R. Caldwell, "SimplyAgree: an R package and jamovi module for simplifying agreement and reliability analyses," Journal of Open Source Software, vol. 7, no. 71, p. 4148, 2022. doi: 10.21105/joss.04148. DOI: https://doi.org/10.21105/joss.04148

J. Chiarelli, M. A. St. Hilaire, B. L. Baldock, J. Franco, S. Theberge, and A. L. Fernandez, "Calculating the precision of student-generated datasets using RStudio," Journal of Chemical Education, vol. 102, no. 2, pp. 909-916, 2025. doi: 10.1021/acs.jchemed.4c00870. DOI: https://doi.org/10.1021/acs.jchemed.4c00870

P. Soysal, F. Arik, L. Smith, S. E. Jackson, and A. T. Isik, "Inflammation, frailty and cardiovascular disease," Frailty and cardiovascular diseases: Research into an Elderly Population, pp. 55-64, 2020. doi: 10.1007/978-3-030-33330-0_7. DOI: https://doi.org/10.1007/978-3-030-33330-0_7

P. Libby, "The changing landscape of atherosclerosis," Nature, vol. 592, no. 7855, pp. 524-533, 2021. doi: 10.1038/s41586-021-03392-8. DOI: https://doi.org/10.1038/s41586-021-03392-8

J. F. Aranda, C. M. Ramírez, and M. Mittelbrunn, "inflammageing, a targetable pathway for preventing cardiovascular diseases," Cardiovascular Research, vol. 121, no. 10, pp. 1537-1550, 2025. doi: 10.1093/cvr/cvae240. DOI: https://doi.org/10.1093/cvr/cvae240

F. De Luca et al., "From Senescent Cells to Systemic inflammation: The Role of inflammaging in Age-Related Diseases and Kidney Dysfunction," Cells, vol. 14, no. 22, p. 1831, 2025. doi: 10.3390/cells14221831. DOI: https://doi.org/10.3390/cells14221831

A. Bayes-Genis et al., "Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: a clinical consensus statement from the Heart Failure Association of the ESC," European Journal of Heart Failure, vol. 25, no. 11, pp. 1891-1898, 2023. doi: 10.1002/ejhf.3036. DOI: https://doi.org/10.1002/ejhf.3036

K. Davidson-Turner, M. P. Farina, and M. D. Hayward, "Racial/ethnic differences in inflammation levels among older adults 56+: an examination of sociodemographic differences across inflammation measure," Biodemography and Social Biology, vol. 69, no. 2, pp. 75-89, 2024. doi: 10.1080/19485565.2024.2356672. DOI: https://doi.org/10.1080/19485565.2024.2356672

E. Zhou, J. Wu, X. Zhou, and Y. Yin, "Systemic inflammatory biomarkers are novel predictors of all-cause and cardiovascular mortality in individuals with osteoarthritis: a prospective cohort study using data from the NHANES," BMC Public Health, vol. 24, no. 1, p. 1586, 2024. doi: 10.1186/s12889-024-19105-5. DOI: https://doi.org/10.1186/s12889-024-19105-5

A. Gaafar, A. A. Sedeek, M. Farouk, and Y. A. Sadek, "Assessment of soluble ST2 as a biomarker for cardiac remodeling in heart failure patients," Al-Azhar International Medical Journal, vol. 2025, no. 11, pp. 1-8, 2025. doi: 10.21608/aimj.2025.403866.2656. DOI: https://doi.org/10.21608/aimj.2025.403866.2656

K. N. Abdulla, R. K. Khudhur, A. M. Said, A. H. Jumaa, and Y. S. Yasin, "Laetrile and methotrexate: A dual-drug approach to inhibiting cervical cancer cell proliferation," Journal of Cancer Research Updates, vol. 14, pp. 52-62, 2025. doi: 10.30683/1929-2279.2025.14.06. DOI: https://doi.org/10.30683/1929-2279.2025.14.06

M. Bonaccio et al., "A score of low-grade inflammation and risk of mortality: prospective findings from the Moli-sani study," Haematologica, vol. 101, no. 11, p. 1434, 2016. doi: 10.3324/haematol.2016.144055. DOI: https://doi.org/10.3324/haematol.2016.144055

M. Puzianowska-Kuźnicka et al., "Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study," Immunity and Ageing, vol. 13, no. 1, p. 21, 2016. doi: 10.1186/s12979-016-0076-x. DOI: https://doi.org/10.1186/s12979-016-0076-x

T. Takahashi and A. Iwasaki, "Sex differences in immune responses," Science, vol. 371, no. 6527, pp. 347-348, 2021. doi: 10.1126/science.abe7199. DOI: https://doi.org/10.1126/science.abe7199

T. T. Al-Mahdwi, A. M. Said, I. M. Hade, Y. S. Yasin, and A. H. Jumaa, "Synergistic cytotoxic impact of linagliptin-ciprofloxacin combination on cervical cancer cell line: insights into targeting heat shock protein 60," Asian Pacific Journal of Cancer Prevention, vol. 26, no. 6, p. 2117, 2025. doi: 10.31557/APJCP.2025.26.6.2117. DOI: https://doi.org/10.31557/APJCP.2025.26.6.2117

C. Murphy, E. Deplazes, C. G. Cranfield, and A. Garcia, "The role of structure and biophysical properties in the pleiotropic effects of statins," International Journal of Molecular Sciences, vol. 21, no. 22, p. 8745, 2020. doi: 10.3390/ijms21228745. DOI: https://doi.org/10.3390/ijms21228745

M. I. Mubarok, M. Rochmanti, M. Yusuf, and M. Thaha, "The anti-inflammatory effect of ACE-I/ARBs drug on hs-CRP and HDL-cholesterol in CKD patient," Indian Journal of Forensic Medicine and Toxicology, vol. 15, no. 3, pp. 3743-3750, 2021. doi: 10.37506/ijfmt.v15i3.15878. DOI: https://doi.org/10.37506/ijfmt.v15i3.15878

M. Ekholm and T. Kahan, "The impact of the renin-angiotensin-aldosterone system on inflammation, coagulation, and atherothrombotic complications, and to aggravated COVID-19," Frontiers in Pharmacology, vol. 12, p. 640185, 2021. doi: 10.3389/fphar.2021.640185. DOI: https://doi.org/10.3389/fphar.2021.640185

P. M. Ridker and M. Rane, "Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease," Circulation Research, vol. 128, no. 11, pp. 1728-1746, 2021. doi: 10.1161/circresaha.121.319077. DOI: https://doi.org/10.1161/CIRCRESAHA.121.319077